LON:IDH Immunodiagnostic Systems (IDH) Share Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Immunodiagnostic Systems Stock (LON:IDH) Get IDH alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume14,539 shsMarket Capitalization£108.80 millionP/E Ratio290.77Dividend Yield0.50%Price TargetN/AConsensus RatingN/A Company Overview Immunodiagnostic Systems Holdings PLC develops, manufactures, and sells in-vitro diagnostic tests to the clinical laboratory market in the United Kingdom, the United States, Germany, France, and internationally. It develops, manufactures, and markets immunoassays and automated immunoanalyser technologies to provide diagnostic outcomes for patients. It offers IDS-iSYS multi-discipline automated systems, which is based on chemiluminescence and absorbency technology is used for immunoassay testing. The company provides its products and services for diagnosis of bone metabolism, calcium metabolism, hypertension, chronic kidney disease mineral bone disorder, growth, fertility, autoimmunity, infectious disease, sarcoidosis, and allergy. Immunodiagnostic Systems Holdings PLC was founded in 1977 and is headquartered in Boldon, the United Kingdom. Read More Receive IDH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Immunodiagnostic Systems and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IDH Stock News HeadlinesEQS-News: DATAGROUP Acquires ISC Innovative Systems Consulting AGMarch 25, 2024 | markets.businessinsider.com2025 Volkswagen ID.7 First Drive Review: Okay, I Get It NowMarch 21, 2024 | msn.comTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.June 19 at 1:00 AM | Altimetry (Ad)Volkswagen ID.4 Makes Debut In India, Set To Hit Roads SoonMarch 21, 2024 | msn.comFarewell, Fake IDs: Age Verification Gets an UpgradeAugust 8, 2023 | msn.comRevenues and profits rise at Immunodiagnostic Systems in year after £110m takeoverJune 26, 2023 | msn.comIDH.L Regulatory NewsJune 20, 2023 | lse.co.ukImmunohistochemistry (IHC) Market worth $4.7 billion | MarketsandMarketsJune 9, 2023 | finanznachrichten.deSee More Headlines IDH Stock Analysis - Frequently Asked Questions How were Immunodiagnostic Systems' earnings last quarter? Immunodiagnostic Systems Holdings PLC (LON:IDH) issued its quarterly earnings results on Wednesday, June, 20th. The company reported $5.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.60 by $3.10. How do I buy shares of Immunodiagnostic Systems? Shares of IDH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Immunodiagnostic Systems own? Based on aggregate information from My MarketBeat watchlists, some other companies that Immunodiagnostic Systems investors own include Dechra Pharmaceuticals (DPH), iShares Biotechnology ETF (IBB), Redrow (RDW), Netflix (NFLX), Sysco (SYY), TP ICAP Group (TCAP) and Telford Homes (TEF). Company Calendar Last Earnings6/20/2018Today6/19/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Appliances & Equipment Sub-IndustryN/A Current SymbolLON:IDH CIKN/A Webwww.idsplc.com Phone+44-191-5190660FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E Ratio290.77 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio6.84 Current Ratio5.40 Quick Ratio3.87 Sales & Book Value Annual Sales£34.25 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow4.50 Book ValueGBX 187.60 per share Price / BookN/AMiscellaneous Outstanding Shares28,784,000Free FloatN/AMarket Cap£108.80 million OptionableNot Optionable BetaN/A Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (LON:IDH) was last updated on 6/19/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredThis is the worst news for stocks in 50 yearsGoldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...TradeSmith | SponsoredA huge SpaceX error just led one stock to 3X move!SPCE surged roughly 300% in a single week after investors hunting SpaceX exposure piled into the wrong ticker....InvestPub | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredThe roadshow starts Monday. This stock isn't ready.The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...Behind the Markets | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunodiagnostic Systems Holdings PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Immunodiagnostic Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
